Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ian M. Bell, Harleysville US

Ian M. Bell, Harleysville, PA US

Patent application numberDescriptionPublished
20080214511Tricyclic Anilide Spirolactam Cgrp Receptor Antagonists - The present invention is directed to compounds of Formula I: I (where A09-04-2008
20080318927Substituted monocyclic CGRP receptor antagonists - Compounds of formula I:12-25-2008
20090054408Monocyclic anilide spirolactam cgrp receptor antagonists - The present invention is directed to compounds of Formula I: I (where A02-26-2009
20090105219Spirolactam Tricyclic CGRP Receptor Antagonists - Compounds of formula I:04-23-2009
20090176757Bicyclic Spirohydantoin CGRP Receptor Antagonists - Compounds of formula I:07-09-2009
20090221535IMMUNOGENIC COMPOSITIONS FOR GRAM POSITIVE BACTERIA SUCH AS STREPTOCOCCUS AGALACTIAE - The present invention is directed to compounds of Formula I: I (where A09-03-2009
20090239870Spirohydantoin Aryl Cgrp Receptor Antagonists - Compounds of formula I:09-24-2009
20090247514Spirolactam aryl cgrp receptor antagonists - Compounds of formula I:10-01-2009
20090281080Spirohydantoin Tricyclic CGRP Receptor Antagonists - Compounds of formula I:11-12-2009
20090325991Spirolactam Bicyclic CGRP Receptor Antagonists - Compounds of formula I:12-31-2009
20100056498SUBSTITUTED MONOCYCLIC CGRP RECEPTOR ANTAGONISTS - Compounds of formula I:03-04-2010
20100069359CONSTRAINED SPIROCYCLIC COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS - Compounds of formula I:03-18-2010
20100093759BICYCLIC ANILIDE HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS - Compounds of formula I: I (wherein variables A1, A2, B, m, n, J, R4, G1, G2, G3 and Y are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.04-15-2010
20100120809ARYL HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS - Compounds of formula I:05-13-2010
20100152216MONOCYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS - The present invention is directed to compounds of Formula I:06-17-2010
20100160334TRICYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS - The present invention is directed to compounds of Formula I: I (where A06-24-2010
20100298269PRODRUGS OF CGRP RECEPTOR ANTAGONISTS - Disclosed are prodrug compounds of formula (I) (wherein variables R11-25-2010
20100324023IMIDAZOBENZAZEPINE CGRP RECEPTOR ANTAGONISTS - Compounds of Formula I: I (where variables R12-23-2010
20110021516MONOCYCLIC CGRP RECEPTOR ANTAGONISTS - The present invention is directed to compounds of the formula (I): (wherein variables A01-27-2011

Patent applications by Ian M. Bell, Harleysville, PA US